Life Science

Global Influenza Medication Market Report: Regional Data Analysis by Production, Revenue, Price and Gross Margin

Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.

In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.

Access Report Details at:

The global Influenza Medication market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Influenza Medication volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza Medication market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Key companies profiled in Influenza Medication Market report are Daiichi Sankyo Company, Glaxosmithkline, Natco Pharma, F. Hoffmann-La Roche, Teva Pharmaceutical, Sandoz International Gmbh (Novartis Ag), Sun Pharmaceutical Industries, Mylan and more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc.

Purchase this Premium Report at:

Table of Content

1 Influenza Medication Market Overview

2 Global Influenza Medication Market Competition by Manufacturers

3 Global Influenza Medication Production Market Share by Regions

4 Global Influenza Medication Consumption by Regions

5 Global Influenza Medication Production, Revenue, Price Trend by Type

6 Global Influenza Medication Market Analysis by Applications

7 Company Profiles and Key Figures in Influenza Medication Business

8 Influenza Medication Manufacturing Cost Analysis

9 Marketing Channel, Distributors and Customers

10 Market Dynamics

11 Global Influenza Medication Market Forecast

12 Research Findings and Conclusion

13 Methodology and Data Source